BUSCLAB - Buscopan to Prevent Slow Progress in Labor

Labor (Obstetrics)--Complications Clinical Trial

Official title:
BUSCLAB - A Double Blind Randomized Placebo-Controlled Trial Investigating the Effect of Intravenous Butylscopolamine Bromide to Prevent Slow Progress in Labor

Status Completed

Clinical Trial Summary

To study the effect of Butylscopolamine Bromide on duration of the active phase of first stage of labor in first time mothers who cross the alert-line for labor dystocia, according to the WHO partograph.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Labor (Obstetrics)--Complications
Labor; Prolonged, First Stage

Clinical Trial Details

NCT number	NCT03961165
Study type	Interventional
Source	Oslo University Hospital
Contact
Status	Completed
Phase	Phase 3
Start date	May 25, 2019
Completion date	June 16, 2022

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05560802` - Can the Use of a Next Generation Partograph Improve Neonatal Outcomes? (PICRINO)	N/A
Not yet recruiting	`NCT05791630` - The Norwegian World Health Organisation Labour Care Guide Trial (NORWEL)	N/A
Recruiting	`NCT04251702` - Biomarkers of Uterine Muscle Physiology
Recruiting	`NCT06405984` - Trans-Abdominal Fetal Pulse Oximetry - EFS-IDE	Early Phase 1
Completed	`NCT04551690` - Prevalence of COVID-19 (Coronavirus Disease 19) in Pregnant Women on Labor in a Public Hospital in Chile (COroNavirus diSease Covid-19 pandEmic iN ChilE)